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CORRECTION
Correction to: Dietary antioxidative supplements and diabetic
retinopathy; a systematic review
Ozra Tabatabaei-Malazy1,2 & Edris Ardeshirlarijani3 & Nazli Namazi4 & Shekoufeh Nikfar2,5,6,7 & Reza Baradar Jalili8 &
Bagher Larijani2
# Springer Nature Switzerland AG 2019
Correction to: Journal of Diabetes &Metabolic Disorders.
https://doi.org/10.1007/s40200-019-00434-x
Please note the following corrections to the original article.
The 2nd author affiliation should read Endocrinology and
Metabolism Research Center, Endocrinology andMetabolism
Clinical Sciences Institute, Tehran University of Medical
Sciences, Tehran, Iran.
The 3rd author affiliation should read Simo Fraser
University, Burnaby, Canada.
Corrections in Tables 1 and 2 as follows:
1- in t1.10: Lam et al.: pleasemove up these words “r = 0.33”;
2- The first “I” in “lipid profile” line t1.17 should be capital.
3 “ARIC study and its expansion” has been deleted from
footnote of Table 1.
4 In t2.4 it should read Se and not sel.
In the Introduction the first line should read ‘Diabetic ret-
inopathy (DR) that is definded as retinal micro-vascular lesion
in subjects with diabetes classified...’
The original article has been corrected’.
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/
10.1007/s40200-019-00434-x
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